Pharma & CDMOKOSPI 001060608 approvals64 trials

JW PHARMACEUTICAL

Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1945 and listed on KOSPI in 1976, JW Pharmaceutical is a pharmaceutical company. It holds an original drug pipeline including Rivalo, Hemlibra, Trupass, Sigmart, and Actemra, plus the third-generation three-chamber nutritional IV fluid Winuf, combining omega-3 and omega-6, and it obtained approval for a combination new drug pairing pitavastatin with ezetimibe. In its 70th fiscal year, separate-entity revenue rose 8.0% (about KRW 56.6 billion) year-on-year to KRW 767.2 billion and operating profit rose 18.1% (about KRW 14.8 billion) to KRW 96.6 billion, and in August 2019 the company acquired 100% of Vietnam's Euvipharm.

Products & technology

Rivalo
Hemlibra
Trupass
Sigmart
Actemra
WinufThird-generation three-chamber nutritional IV fluid combining omega-3 and omega-6
HwakolComprehensive cold medicine (OTC)
HimomWound-type care band (OTC)
Friends EyedropArtificial tears (OTC)
Pitavastatin-Ezetimibe combination drugCombination new drug for circulatory/endocrine indications

Regulatory approvals

data.go.kr

314 Korean MFDS drug approvals · 1955–2026 / 294 Korean MFDS device approvals · 1977–2026

MFDS drugGANETOCTHIONE Tab.2026-08-21
Drug · OTC · Notification202602422
MFDS drugJPCAB Tablet 10mg(Vonoprazan Fumarate)2026-07-08
Drug · Prescription · Approval202601988
MFDS drugJPCAB Tablet 20mg(Vonoprazan Fumarate)2026-07-08
Drug · Prescription · Approval202601989
MFDSDiagnostic spirometer2026-06-04
Product approval · Class 2수인 26-4383 호
MFDS drugEmpa-guard100/12.5mg2026-05-11
Drug · Prescription · Approval202601360
MFDS drugEmpa-guard100/5mg2026-05-11
Drug · Prescription · Approval202601361
MFDS drugThruenza Soft Capsule 40mg2026-04-30
Drug · Prescription · Approval202601305
MFDS drugFacol C Cough S Soft Cap.2026-04-21
Drug · OTC · Notification202601162
MFDS drugLivaloZet Tablet 1/10mg2026-03-12
Drug · Prescription · Approval202600749
MFDS drugFacol Nose Tab.2026-02-03
Drug · OTC · Notification202600303
MFDS drugJritol Tab.2026-01-22
Drug · Prescription · Approval202600199
MFDS drugLIVALO HI Tab 2/160/10mg2025-09-30
Drug · Prescription · Approval202502593

Show 68 more

MFDS drugLIVALO HI Tab 2/160/5mg2025-09-30
Drug · Prescription · Approval202502594
MFDSDiagnostic spirometer2025-09-26
Product approval · Class 2수인 25-4567 호
MFDS drugLIVALO HI Tab 4/160/10mg2025-09-24
Drug · Prescription · Approval202502532
MFDS drugLIVALO HI Tab 2/80/5mg2025-09-24
Drug · Prescription · Approval202502533
MFDS drugLIVALO HI Tab 4/160/5mg2025-09-24
Drug · Prescription · Approval202502534
MFDS drugLIVALO HI Tab 4/80/5mg2025-09-24
Drug · Prescription · Approval202502535
MFDSLight system, surgical2025-08-11
Product approval · Class 1수신 25-1743 호
MFDSLight system, surgical2025-07-22
Product approval · Class 1수신 25-1575 호
MFDS drugLivaloFeno Cap.2025-05-29
Drug · Prescription · Approval202501340
MFDS drugJCLE Tab.2025-05-27
Drug · Prescription · Approval202501316
MFDSLight system, surgical2025-05-16
Product approval · Class 1수신 25-977 호
MFDSCamera, still, surgical2025-05-15
Product approval · Class 1수신 25-966 호
MFDS drugJW ibuprofen premix2025-04-07
Drug · Prescription · Approval202500806
MFDS drugASBERIN capsule 100/5mg2025-03-27
Drug · Prescription · Approval202500715
MFDS drugTavalisse Tab. 150mg2025-01-20
Drug · Prescription · Approval202500147
MFDS drugTavalisse Tab. 100mg2025-01-20
Drug · Prescription · Approval202500148
MFDS drugFacol Tab.2024-11-21
Drug · OTC · Notification202402751
MFDSTable, operation, electrically-powered2024-11-08
Product approval · Class 1수신 24-2120 호
MFDSPatient positioning or immobilization device2024-10-29
Product approval · Class 1수신 24-2032 호
MFDS drugFrenz Eye One Cool Eye Drops(Carboxymethylcellulose sodium)(single use)2024-09-19
Drug · OTC · Notification202402254
MFDS drugRABEKHAN DUO Tab. 20/700mg2024-08-30
Drug · Prescription · Approval202402099
MFDS drugRABEKHAN DUO Tab. 10/700mg2024-08-30
Drug · Prescription · Approval202402100
MFDS drugFrenz Eyedrop Ice2024-04-11
Drug · OTC · Notification202400824
MFDS drugMobilia Inj.(Plerixafor)2023-11-21
Drug · Prescription · Approval202303176
MFDS drugJardimet Tab. 12.5/850mg2023-09-04
Drug · Prescription · Approval202302630
MFDS drugJardimet Tab. 12.5/1000mg2023-09-04
Drug · Prescription · Approval202302631
MFDS drugJardimet Tab. 12.5/500mg2023-09-04
Drug · Prescription · Approval202302632
MFDS drugAlgyquick Soft Cap.2023-08-22
Drug · OTC · Notification202302483
MFDSIncubator, infant2022-12-05
Product approval · Class 3제허 22-821 호
MFDSIncubator, infant2022-11-24
Product approval · Class 3제허 22-795 호
MFDSIncubator, infant2022-11-22
Product approval · Class 3제허 22-786 호
MFDS drugENAROY tablet 1mg(Enarodustat)2022-11-17
Drug · Prescription · Approval202204160
MFDS drugENAROY tablet 2mg(Enarodustat)2022-11-17
Drug · Prescription · Approval202204161
MFDS drugENAROY tablet 4mg(Enarodustat)2022-11-17
Drug · Prescription · Approval202204162
MFDSX-ray system, diagnostic, general-purpose, digitalRevoked2022-09-29
Product approval · Class 2제인 22-4730 호
MFDSX-ray system, diagnostic, general-purpose, digitalRevoked2022-09-29
Product approval · Class 2제인 22-4729 호
MFDSIncubator, infant2022-08-23
Product approval · Class 3제허 22-572 호
MFDSIncubator, infant2022-08-23
Product approval · Class 3제허 22-571 호
MFDSIncubator, infant2022-08-23
Product approval · Class 3제허 22-568 호
MFDS drugJW Donepezil Sol2022-07-18
Drug · Prescription · Approval202202999
MFDSPatient positioning or immobilization deviceRevoked2022-05-09
Product approval · Class 1수신 22-800 호
MFDS drugJardimet Tab. 5/850mg2022-04-29
Drug · Prescription · Approval202201741
MFDS drugJardimet Tab. 5/500mg2022-04-29
Drug · Prescription · Approval202201742
MFDS drugJardimet Tab. 5/1000mg2022-04-29
Drug · Prescription · Approval202201743
MFDS drugFrenz eyedrop care(single use)2022-03-24
Drug · OTC · Notification202201175
MFDS drugSUBRION Injection(sugammadex sodium)2022-02-11
Drug · Prescription · Approval202200671
MFDSPatient positioning or immobilization deviceRevoked2021-12-28
Product approval · Class 1수신 21-2355 호
MFDS drugLivaloZet Tablet 2/10mg2021-07-28
Drug · Prescription · Approval202105578
MFDS drugLivaloZet Tablet 4/10mg2021-07-28
Drug · Prescription · Approval202105579
MFDSTable, examination/treatment, gynaecological, electrically- poweredRevoked2021-06-30
Product approval · Class 1수신 21-1213 호
MFDSLight, examination, mobile2021-06-11
Product approval · Class 1수신 21-1078 호
MFDSLight, examination, mobile2021-05-26
Product approval · Class 1수신 21-943 호
MFDSLight system, surgical2021-04-30
Product approval · Class 1제신 21-594 호
MFDSLight system, surgical2021-04-09
Product approval · Class 1수신 21-595 호
MFDSTable, operation, electrically-powered2021-03-30
Product approval · Class 1수신 21-528 호
MFDSLight, examination2021-03-23
Product approval · Class 1수신 21-469 호
MFDSCamera, still, surgical2021-03-17
Product approval · Class 1수신 21-440 호
MFDS drugJardiheart Tab. 25mg(Empagliflozin)2021-03-12
Drug · Prescription · Approval202102269
MFDS drugJardiheart Tab. 10mg(Empagliflozin)2021-03-12
Drug · Prescription · Approval202102270
MFDS drugGANETOC Solution2021-03-05
Drug · OTC · Notification202102087
MFDSDiagnostic spirometer2021-03-04
Product approval · Class 2수인 21-4089 호
MFDS drugRABEGRONRevoked2021-02-18
Drug · Prescription · Approval202101474
MFDSTable, examination/treatment, general-purpose, electrohydraulic2020-12-11
Product approval · Class 1제신 20-1840 호
MFDSTable, examination/treatment, general-purpose, electrohydraulicRevoked2020-12-11
Product approval · Class 1제신 20-1836 호
MFDS drugMydrop eye drop (polydeoxyribonucleotide sodium)(single use)2020-11-23
Drug · OTC · Notification202008115
MFDS drugMOENDEX Tab. 100mgRevoked2020-11-18
Drug · OTC · Notification202007966
MFDS drugJRELTO Tab. 15mgRevoked2020-09-04
Drug · Prescription · Approval202006171
MFDS drugJRELTO Tab. 10mgRevoked2020-09-04
Drug · Prescription · Approval202006172

Showing the 80 most recent of 608 records.

Clinical trials

data.go.kr

64 MFDS clinical trial authorisations · 2012–2026 (Phase 1 36 · Bioequivalence 14 · Phase 3 9 · Phase 2a 3 · Phase 2b 1)

Phase 1JW01122026-07-02
2 trial sites
Phase 1JW01122026-07-02
2 trial sites
Phase 1JW01112026-04-30
2 trial sites
Phase 1JW0901 C25022026-03-19
2 trial sites
Phase 1JW00612026-02-12
1 trial site
Phase 1URC102정2025-12-08
1 trial site
Phase 3KLH-21092025-09-22
55 trial sites
Phase 1JW0104, C24092025-06-11
2 trial sites
Phase 1JW0104, C2409, C24102025-06-11
2 trial sites
BioequivalenceJW06022025-01-13
2 trial sites
Phase 3JW0108, C24072025-01-06
14 trial sites
Phase 1JW01052024-10-07
1 trial site

Show 52 more

Phase 3JW0104, C24022024-08-30
20 trial sites
Phase 1URC102정2024-07-30
1 trial site
Phase 1JW01072024-06-26
1 trial site
Phase 1JW22862024-06-18
1 trial site
Phase 1JW02042024-04-17
1 trial site
Phase 1URC102정2024-02-19
1 trial site
Phase 1JW02022023-08-02
2 trial sites
Phase 1JW0104, C22072023-06-27
2 trial sites
Phase 1JW02032023-03-23
1 trial site
Phase 1JW01022023-02-10
2 trial sites
Phase 1JW03022023-01-10
1 trial site
Phase 3URC102정2022-11-24
29 trial sites
Phase 3JW02012022-09-28
34 trial sites
Phase 3JW02012022-09-28
20 trial sites
Phase 1JW03012022-05-13
1 trial site
Phase 1URC102정2021-11-12
2 trial sites
Phase 1JW02012021-11-11
1 trial site
Phase 3JW0101/C21012021-08-09
21 trial sites
Phase 1리바로VA정4/160/10밀리그램2021-05-04
1 trial site
Bioequivalence에소메칸정40밀리그램(에스오메프라졸마그네슘삼수화물)2021-04-27
2 trial sites
Bioequivalence제이더블유중외제약도네페질정10밀리그램(도네페질염산염수화물)2020-11-12
2 trial sites
Phase 1리바로정4밀리그램(피타바스타틴칼슘), 디오반필름코팅정160밀리그램(발사르탄), 노바스크정10밀리그램(암로디핀베실산염)2020-08-28
1 trial site
Bioequivalence리바로정1밀리그램(피나바스타틴칼슘)2019-09-03
2 trial sites
Bioequivalence리바로정2밀리그램(피타바스타틴칼슘)2019-08-09
2 trial sites
Phase 3JW0108, C24072019-06-11
25 trial sites
Phase 2bURC102정2018-11-15
10 trial sites
Phase 1JW16012018-11-06
2 trial sites
Phase 1리바로E정4/10mg(가칭)2018-10-19
1 trial site
Phase 4가드렛정 100mg2018-10-19
27 trial sites
Phase 3JTZ-9512018-08-07
28 trial sites
Phase 1리바로E정4/10mg(가칭)2018-08-06
1 trial site
Bioequivalence올멕포스에이치정 5/20/12.5 밀리그램2017-09-01
2 trial sites
Bioequivalence제이다트정0.5밀리그램(두타스테리드)2017-04-05
2 trial sites
Bioequivalence올멕포스에이치정 10/40/12.5밀리그램2017-02-13
2 trial sites
Phase 2aCWP232291(가칭)2016-12-14
3 trial sites
Phase 1테노펙션정2016-02-01
1 trial site
Phase 2aURC102정2015-07-31
4 trial sites
Phase 1URC102정2015-06-29
1 trial site
Bioequivalence페북사트정(페북소스타트)2015-03-09
2 trial sites
Phase 1CWP232291(가칭)2015-02-25
3 trial sites
Phase 1가드렛복합정100/1000mg(가칭)2014-12-09
1 trial site
Bioequivalence트루패스디정8밀리그램(실로도신)2014-07-11
2 trial sites
Phase 1아나글립틴(Anagliptin)2014-06-02
1 trial site
Phase 2aURC102정2014-04-07
5 trial sites
Phase 1리바로복합정4/160mg(가칭)2014-02-27
1 trial site
Bioequivalence제이더블유중외제약주식회사 제이카정(가칭)(Amlodipine besylate 13.888 mg / Olmesartan medoxomil 40 mg)2014-01-14
2 trial sites
Bioequivalence리바로정2밀리그램(피타바스타틴칼슘)2013-05-28
2 trial sites
Phase 1URC102정2013-05-02
1 trial site
Phase 1리바로정, 디오반필름코팅정2012-12-10
1 trial site
Bioequivalence중외로잘탄정(로자탄칼륨)2012-09-05
Bioequivalence발사포스정10/160밀리그램2012-06-29
1 trial site
Phase 1CWP232291(가칭)2012-02-15
3 trial sites

R&D and key agreements

Source: DART corporate disclosure

C&C신약연구소 · Joint-venture new drug research institute established with Chugai Pharmaceutical of Japan in 1992

JW Theriac · Chemogenomics research institute established in Seattle, US in 2001

AI reads

MAA server logs · IP-verified

Read to answer a question

Someone asked an AI a question, and it fetched this page live to answer.

Crawled for indexing

Collected for later use. Not a signal of interest.

1answer

index 0

Last 7 days

1answer

index 0

Last 30 days

1answer

index 0

All time

OpenAIChatGPT-Useranswer1

Measured since Aug 26, 2026 · 1 AI engines · last read Aug 26, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.

Connect this index to your AI tool →

Not yet compiled: business overview. Send us materials and we will add them

Company facts

Founded: 1945
Listed: 1976
Market: KOSPI 001060
CEO: 대표이사 신영섭
Location: Gyeonggi
Category: Pharma & CDMO

Performance

Consolidated · DART

Year	Revenue	Op. profit
2025	₩775.3B	₩94.5B
2024	₩719.4B	₩82.5B
2023	₩748.5B	₩100.3B

AI visibility

2026-08-13

82/ 100

✓Crawler access

✗Structured data

✓Sitemap

✓HTTPS

✓English pages

✗llms.txt

Keywords

pharmaceuticaliv-fluidsoriginal-drugotckospi

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

SHINHUNG CO.,LTD16 shared

Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.

Alpha AI Co.,Ltd.12 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

DONG-A ST CO.,LTD10 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

GC Medical Science Corporation10 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Bistos Co., Ltd.8 shared

Founded in 2001 and KOSDAQ-listed in 2022, Bistos manufactures fetal, neonatal, and patient monitoring medical devices.

DENTIS CO.,LTD8 shared

Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.

ValueAddedTechnologyCo.,Ltd.6 shared

Founded in 1992 and KOSDAQ-listed in 2006, VATECH manufactures dental digital X-ray and CT imaging diagnostic devices.

SEWOONMEDICAL CO,. LTD.5 shared

Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.

BIODYNE CO., LTD.4 shared

Founded in 1999 and KOSDAQ-listed in 2021, BIODYNE develops liquid-based cytology (LBC) devices and diagnostic reagent kits.

DRTECH Corporation4 shared

KOSDAQ-listed digital diagnostic imaging company providing X-ray systems, detectors, and components.

HANS BIOMED CORPORATION4 shared

KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.

SGHEALTHCARE CO.,LTD.4 shared

Founded in 2009 and KOSDAQ-listed in 2024, SGHealthcare manufactures X-ray, CT, and MRI medical imaging diagnostic devices.

Sources and updates

Company basics: Korea Exchange · DART
Business content: Compiled from disclosure filings
AI visibility: Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition